View Older Stories View More Recent Stories
-
Minerva Launches AI Platform for Consumer Marketing with $20M from The General Partnership, 8VC, Lingotto Innovation, Topology Ventures and NBA Investments, Alongside OpenAI Collaboration
-
UBS Reiterates Neutral Rating on Lazard (LAZ) Ahead of May AUM Data
-
AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors
-
Incyte to acquire Vega Therapeutics for $1.25 billion upfront
-
Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders
-
Saks Global Secures Court Approval of Plan of Reorganization, Paving the Way for Emergence
-
Form N-MFP3 LAZARD FUNDS INC For: May 31
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: Jarrard Michelle
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: Harrison Peter
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: Alper Andrew M
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: Achleitner Ann-Kristin
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: Shevelenko Dmitry
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: SCHULMAN DANIEL H
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: Knobloch Iris
-
Form 4 Lazard, Inc. For: Jun 01 Filed by: Howe Stephen R. Jr.
-
Ella Curren joins UBS as Financial Advisor in New York City
-
ACA Group Appoints Trey Loughran as Chief Executive Officer
-
Athene names Matthew Michelini president of holding company
-
Athene Announces Key Leadership Appointment
-
Waldencast agrees to sell Obagi Medical to Bridgepoint for up to $460 million
-
Waldencast Announces Sale of Obagi Medical to Bridgepoint
-
€900M European Consulting and Technology Leader Magellan Expands Into UK Market Following Strategic Acquisition of Transport and Mobility Giant MeTS
-
BMO hires UBS banker to lead US M&A team, memo shows
-
Form NPORT-P Lazard Active ETF Trust For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P Lazard Active ETF Trust For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD RETIREMENT SERIES For: Mar 31
-
Form NPORT-P Lazard Active ETF Trust For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P Lazard Active ETF Trust For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD RETIREMENT SERIES For: Mar 31
-
Form NPORT-P LAZARD RETIREMENT SERIES For: Mar 31
-
Form NPORT-P LAZARD GLOBAL TOTAL RETU For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P Lazard Active ETF Trust For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P Lazard Active ETF Trust For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31
-
Form NPORT-P LAZARD RETIREMENT SERIES For: Mar 31
-
Form NPORT-P LAZARD FUNDS INC For: Mar 31

